Cargando…
Current Evidence for the Use of Smoflipid® Emulsion in Critical Care Patients for Parenteral Nutrition
There are strong data showing that malnutrition is highly prevalent in intensive care unit patients (20–50% in the worldwide), presenting a negative accumulated body energy balance. This results in an increased mortality, infections, and hospital length stay with high costs associated with the total...
Autores principales: | Leguina-Ruzzi, Alberto A., Ortiz, Rina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280253/ https://www.ncbi.nlm.nih.gov/pubmed/30584476 http://dx.doi.org/10.1155/2018/6301293 |
Ejemplares similares
-
A commentary on the 2015 Canadian Clinical Practice Guidelines in glutamine supplementation to parenteral nutrition
por: Leguina-Ruzzi, Alberto
Publicado: (2016) -
Erratum to: A commentary on the 2015 Canadian Clinical Practice Guidelines in glutamine supplementation to parenteral nutrition
por: Leguina-Ruzzi, Alberto
Publicado: (2016) -
Ursodeoxycholic Acid and SMOFlipid for Treating Parenteral Nutrition Associated Cholestasis in Infants
por: Al-Alaiyan, Saleh, et al.
Publicado: (2022) -
The streptozotocin-high fat diet induced diabetic mouse model exhibits severe skin damage and alterations in local lipid mediators
por: Leguina-Ruzzi, Alberto, et al.
Publicado: (2018) -
Comparative study of the safety and efficacy of SMOFlipid vs non SMOFlipid as TPN for liver transplantation
por: Wu, Mei-Yun, et al.
Publicado: (2021)